Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2017

Calquence(Acalabrutinib)AstraZeneca PLC logoAZN

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by AstraZeneca PLC

$564K

Medicare cost, 2024

Medicare drug plans spent $564,130 on Calquence (acalabrutinib) in 2024, for 41 prescriptions and refills filled by 18 patients. Spending fell 99% from 2023 to 2024. At about $13,759 per prescription it is a high-cost drug. It is made by AstraZeneca PLC (AZN).

Medicare cost, 2024

$564K

-99.1% from 2023

Prescriptions

41

$13,759.27 per claim

Patients

18

16 prescribers

Total spending, 2024

$564K

$31,340.57 per patient

Questions and answers

How much does Medicare spend on Calquence?

Medicare prescription drug plans paid $564K for Calquence in 2024, for 41 prescriptions and refills to 18 patients (down 99.1% from 2023). The average cost per claim was $13,759.27.

Which state spends the most on Calquence?

Florida had the highest Medicare cost for Calquence in 2024: $185K for 13 claims, followed by Maryland ($160K).

Who prescribes Calquence the most?

Vinicio Hernandez, medical oncology in Orlando, FL, had the highest Medicare cost for Calquence in 2024: 13 claims costing $185K.

Who makes Calquence?

Calquence is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Calquence was $564K in 2024, after a high of $1.03B in 2022.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Calquence, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Vinicio Hernandez Orlando, FLMedical Oncology13Under 11$185K
Kavita B Kalra Baltimore, MDHematology-Oncology12Under 11$160K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20226,39173,90711,179$1.03B
20231,7554,2642,589$59.7M
2024164118$564K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
AstrazenecaAZN logoAZN41$564K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
3
RxNorm concept IDs
1986813, 1986819, 2607734, 2607737
Application numbers
NDA210259, NDA216387

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube